Franklin Stuart Friedman - Jun 8, 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role: Director
Signature: /s/ Jeffrey Held, as Attorney-in-Fact
Stock symbol: DCPH
Transactions as of: Jun 8, 2023
Transactions value $: $138,828
Form type: 4
Date filed: 6/12/2023, 04:05 PM
Previous filing: Jan 19, 2023
Next filing: Jun 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DCPH	Common Stock	Purchase	$139K	+10K		$13.88	10K	Jun 8, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.87 to $13.89, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.87 to $13.89, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.